Dolby up as co set to replace Staar Surgical in S&P MidCap 400
** Shares of audio and imaging product maker Dolby
Laboratories DLB.N up over 8% at $83.25
** DLB set to replace Staar Surgical STAA.O in S&P MidCap
400 effective on Aug. 22
** Staar Surgical will replace Urstadt Biddle Properties
UBA.N in S&P SmallCap 600
** Up to last close, DLB stock had risen 8.9% this year
(Reporting by Vedant Vinayak Vichare in Bengaluru)
((vedant.vinayakvichare@thomsonreuters.com))
Recent news on Dolby Laboratories
See all newsBrief: Dolby Laboratories Announces Leadership Transition
Dolby Laboratories Inc reports results for the quarter ended June 30 - Earnings Summary
Dolby Laboratories Q3 revenue falls more than expected
Entertainment firm Dolby Laboratories beats Q2 revenue expectations
Dolby Q1 revenue beats expectations, helped by strong momentum in Dolby Atmos and Dolby Vision technologies